New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
 
 

RELATED ARTICLES

HIV Envelope Trimer Immunization Approach Optimized

News

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

READ MORE

Wyss Institute’s Organ Chips Get Smart and Go Electric

News

Human Organs-on-Chips technology has been enhanced to non-invasively report cells’ health, electrical activities and differentiation status

READ MORE

International Team Identify Druggable Target to Fight Fungus Candida Albicans

News

Researchers from USC and Universite Grenoble Alpes, France identified that Bdf1, a gene-regulating protein, is critical for the survival of the pathogenic fungus Candida albicans.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE